|
|
|
Volumn 27, Issue 3 SUPPL. 5, 2000, Pages 41-43
|
|
A phase I and II study of pentostatin (Nipent) with cyclophosphamide for previously treated patients with chronic lymphocytic leukemia
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACICLOVIR;
ADENOSINE DEAMINASE;
CLADRIBINE;
COTRIMOXAZOLE;
CYCLOPHOSPHAMIDE;
FLUDARABINE;
GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR;
PENTOSTATIN;
BONE MARROW SUPPRESSION;
CHRONIC LYMPHATIC LEUKEMIA;
CLINICAL TRIAL;
CONFERENCE PAPER;
HERPES ZOSTER;
HUMAN;
NEUTROPENIA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PNEUMOCYSTIS PNEUMONIA;
PRIORITY JOURNAL;
ACYCLOVIR;
ANTI-INFECTIVE AGENTS;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ANTIVIRAL AGENTS;
CHEMOPREVENTION;
CHROMOSOMES, HUMAN, PAIR 12;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
COHORT STUDIES;
CYCLOPHOSPHAMIDE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FLOW CYTOMETRY;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HERPES ZOSTER;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
IN SITU HYBRIDIZATION, FLUORESCENCE;
LEUKEMIA, LYMPHOCYTIC, CHRONIC;
NEUTROPENIA;
PATIENT SELECTION;
PENTOSTATIN;
PNEUMONIA, PNEUMOCYSTIS;
REMISSION INDUCTION;
RISK FACTORS;
TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;
TRISOMY;
|
|
EID: 0033917625
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (5)
|
|
References (16)
|
